Erlotinib HCL 150 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FBGC2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,588
Award facts
- Contract value 100% obligated
- $27,587.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27,587.75 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Erlotinib HCL 150 mg tablets (30-count packages). This is a firm fixed price, non-set-aside delivery order with a completion date of August 26, 2025, to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Erlotinib is an oral tyrosine kinase inhibitor used in the treatment of certain non-small cell lung cancers and pancreatic cancers, representing a specialized pharmaceutical commodity critical to military healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. As a prime contractor to the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen Drug Corp maintains a significant portfolio of federal contracts supplying brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to support military and veteran healthcare systems worldwide. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to meet federal procurement requirements for complex pharmaceutical products.
Quick answers
Who was awarded contract SPE2DB25FBGC2?
SPE2DB25FBGC2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FBGC2 worth?
The government has obligated $27,588 on SPE2DB25FBGC2.
Is contract SPE2DB25FBGC2 an order under another contract?
Yes. SPE2DB25FBGC2 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBGC2 competed?
The extent of competition for SPE2DB25FBGC2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award